The FTSE 100 slipped on Friday as investors digested the Bank of England’s rate cut and its “gradual and careful” guidance, with a split vote underscoring inflation worries, especially over food prices. Market bets on further cuts eased. Relx dropped over 2.5%, while AstraZeneca, Unilever, BP, BAE Systems and Rolls-Royce also declined. On the upside, Glencore rose 3% as copper prices climbed on fears of a Chilean mine closure. Antofagasta gained over 2.5%, Rio Tinto 1.7%, and Fresnillo 1.5% as gold advanced on tariff news. GSK added more than 1% after securing a $370 million settlement from CureVac over mRNA patents, along with a 1% royalty on future US sales of Pfizer/BioNTech’s related vaccines. CureVac, once a GSK partner, is being acquired by BioNTech. For the week, the FTSE 100 is slightly higher, rebounding from last week’s decline.